Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
BIIB059, a Humanized Monoclonal Antibody Targeting Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells, Shows Dose-Related Efficacy in a Phase 2 Study in Participants with Active Cutaneous Lupus ErythematosusWerth, V ; Furie, R ; Romero-Diaz, J ; Navarra, S ; Kalunian, K ; van Vollenhoven, R ; Nyberg, F ; Kaffenberger, B ; Sheikh, S ; Radunovic, G ; Huang, XB ; Carroll, H ; Gaudreault, F ; Meyers, A ; Barbey, C ; Musselli, C ; Franchimont, NARTHRITIS & RHEUMATOLOGY, 2020, Vol.72 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
Safety Profile of Belimumab, a B-Lymphocyte Stimulator-Specific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus ErythematosusWallace, DJ ; Navarra, S ; Petri, M ; Gallacher, A ; Guzman, R ; Thomas, M ; Furie, RA ; Zamani, O ; Levy, RA ; van Vollenhoven, RF ; Cooper, S ; Zhong, ZJ ; Freimuth, W ; Pineda, L ; Cervera, RARTHRITIS AND RHEUMATISM, 2011, Vol.63 (10), p.S220Texto completo disponível |